Physician profile
John Light Parks
NPI 1598928079
$10,789.65
in general payments reported to CMS, 2019-2025
34 companies · $1,190 in 2025
The $1,190 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,326 · 2020: $1,146 · 2021: $4,758 · 2022: $756 · 2023: $791 · 2024: $824 · 2025: $1,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,804.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $5,122.00 | 2019-2024 | Farxiga |
| Novartis Pharmaceuticals Corporation | $969.75 | 2019-2025 | |
| Abbott Laboratories | $787.20 | 2019-2024 | Diamondback Peripheral |
| Boston Scientific Corporation | $624.93 | 2022-2025 | Wolverine Coronary Cutting Balloon, Watchman Access System, Watchman Flx |
| Edwards Lifesciences Corporation | $520.38 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pfizer INC. | $476.54 | 2019-2025 | |
| Novo Nordisk INC | $352.67 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $237.16 | 2019-2024 | Camzyos, Eliquis |
| Amgen INC. | $212.88 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $198.88 | 2019-2024 | Xarelto |
| Chiesi USA, INC. | $136.53 | 2019-2023 | Kengreal |
| Astellas Pharma US INC | $131.39 | 2019-2023 | Myrbetriq |
| Glaxosmithkline, LLC. | $124.99 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.55 | 2022-2025 | Jardiance |
| Baxter Healthcare | $117.39 | 2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $95.17 | 2024 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $84.82 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $72.63 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $52.48 | 2023 | Optimizer |
| Merck Sharp & Dohme LLC | $50.05 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $39.61 | 2022-2024 | Uptravi, Opsumit |
| Medtronic, INC. | $36.22 | 2023-2025 | Aurora Ev-Icd Mri Surescan, In.Pact Admiral |
| Endologix LLC | $35.86 | 2024 | Torus Stent Graft System, Endocross Device |
| Esperion Therapeutics, INC. | $30.91 | 2020 | |
| Teleflex LLC | $18.36 | 2024 | Manta |
| Stryker Corporation | $18.34 | 2025 | Clottriever Bold Catheter |
| Cardiovascular Systems INC. | $18.30 | 2019 | |
| Bard Peripheral Vascular, INC. | $17.86 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $17.29 | 2024 | |
| Tactile Systems Technology INC | $17.04 | 2023 | Entre Plus, Flexitouch Plus |
| Alnylam Pharmaceuticals INC. | $14.23 | 2025 | Amvuttra |
| Bardy Diagnostics, INC. | $12.50 | 2021 | |
| Z-Medica, LLC | $12.28 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $11.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Parks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.